MAGEA3 and central nervous system cancer: In the grade I–II gliomas, MAGE-A1 (Fig. 2A and B) was expressed mainly in the cytoplasm and membrane, while MAGE-A3 (data not shown) and -A11 (Fig. 3A and B) were expressed in the nuclei of the tumor cells.